These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25147652)

  • 41. Molecular typing of multi-drug resistant Acinetobacter baumannii isolates from clinical and environmental specimens in three Iranian hospitals by pulsed field gel electrophoresis.
    Mohammadi Bardbari A; Mohajeri P; Arabestani MR; Karami M; Keramat F; Asadollahi S; Khodavirdipour A; Alikhani MY
    BMC Microbiol; 2020 Apr; 20(1):101. PubMed ID: 32334533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of biofilm formation among clinical isolates of Acinetobacter baumannii in burn wounds in the west of Iran.
    Hatami Moghadam R; Alvandi A; Akbari N; Jafari P; Abiri R
    Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):30-34. PubMed ID: 30672433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biofilm formation and antibiotic sensitivity in
    Hu S; Lv Y; Xu H; Zheng B; Xiao Y
    Front Cell Infect Microbiol; 2022; 12():953780. PubMed ID: 35967866
    [No Abstract]   [Full Text] [Related]  

  • 44. Adaptations of carbapenem resistant
    Sharma S; Das A; Banerjee T; Barman H; Yadav G; Kumar A
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33739918
    [No Abstract]   [Full Text] [Related]  

  • 45. Genetic characterisation of drug resistance and clonal dynamics of Acinetobacter baumannii in a hospital setting in Mexico.
    Bocanegra-Ibarias P; Peña-López C; Camacho-Ortiz A; Llaca-Díaz J; Silva-Sánchez J; Barrios H; Garza-Ramos U; Rodríguez-Flores AM; Garza-González E
    Int J Antimicrob Agents; 2015 Mar; 45(3):309-13. PubMed ID: 25561030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biocide susceptibilities and biofilm-forming capacities of Acinetobacter baumannii clinical isolates from Malaysia.
    Nor A'shimi MH; Alattraqchi AG; Mohd Rani F; A Rahman NI; Ismail S; Abdullah FH; Othman N; Cleary DW; Clarke SC; Yeo CC
    J Infect Dev Ctries; 2019 Jul; 13(7):626-633. PubMed ID: 32065820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biofilm formation by clinical isolates and the implications in chronic infections.
    Sanchez CJ; Mende K; Beckius ML; Akers KS; Romano DR; Wenke JC; Murray CK
    BMC Infect Dis; 2013 Jan; 13():47. PubMed ID: 23356488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biofilm may not be Necessary for the Epidemic Spread of Acinetobacter baumannii.
    Hu Y; He L; Tao X; Meng F; Zhang J
    Sci Rep; 2016 Aug; 6():32066. PubMed ID: 27558010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pitfalls associated with evaluating enzymatic quorum quenching activity: the case of MomL and its effect on
    Zhang Y; Brackman G; Coenye T
    PeerJ; 2017; 5():e3251. PubMed ID: 28462048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro Comparison of Anti-Biofilm Effects against Carbapenem-Resistant Acinetobacter baumannii: Imipenem, Colistin, Tigecycline, Rifampicin and Combinations.
    Song JY; Cheong HJ; Noh JY; Kim WJ
    Infect Chemother; 2015 Mar; 47(1):27-32. PubMed ID: 25844260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Virulence determinants and biofilm formation of
    Aliramezani A; Soleimani M; Fard RMN; Nojoomi F
    Germs; 2019 Sep; 9(3):148-153. PubMed ID: 31646145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biological features of biofilm-forming ability of Acinetobacter baumannii strains derived from 121 elderly patients with hospital-acquired pneumonia.
    Zhang D; Xia J; Xu Y; Gong M; Zhou Y; Xie L; Fang X
    Clin Exp Med; 2016 Feb; 16(1):73-80. PubMed ID: 25543268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Existence of Biofilm and Biofilm-Associated Virulence Genes in Multi-Drug Resistant Invasive Acinetobacter baumannii Isolates].
    Altınok Ö; Boral B; Ergin A; Eser ÖK
    Mikrobiyol Bul; 2020 Jan; 54(1):40-49. PubMed ID: 32050877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients.
    Zeighami H; Valadkhani F; Shapouri R; Samadi E; Haghi F
    BMC Infect Dis; 2019 Jul; 19(1):629. PubMed ID: 31315572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of bla
    Nirwati H; Hakim MS; Darma S; Mustafa M; Nuryastuti T
    Med J Malaysia; 2018 Oct; 73(5):291-296. PubMed ID: 30350807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Virulence profiles and innate immune responses against highly lethal, multidrug-resistant nosocomial isolates of Acinetobacter baumannii from a tertiary care hospital in Mexico.
    Rosales-Reyes R; Gayosso-Vázquez C; Fernández-Vázquez JL; Jarillo-Quijada MD; Rivera-Benítez C; Santos-Preciado JI; Alcántar-Curiel MD
    PLoS One; 2017; 12(8):e0182899. PubMed ID: 28797068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial susceptibility of Acinetobacter species.
    Seifert H; Baginski R; Schulze A; Pulverer G
    Antimicrob Agents Chemother; 1993 Apr; 37(4):750-3. PubMed ID: 8494371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AdeR-AdeS mutations & overexpression of the AdeABC efflux system in ciprofloxacin-resistant
    Lari AR; Ardebili A; Hashemi A
    Indian J Med Res; 2018 Apr; 147(4):413-421. PubMed ID: 29998878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biofilm-Induced Antibiotic Resistance in Clinical
    Shenkutie AM; Yao MZ; Siu GK; Wong BKC; Leung PH
    Antibiotics (Basel); 2020 Nov; 9(11):. PubMed ID: 33212840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.